Gαi2 inhibition of adenylate cyclase regulates presynaptic activity and unmasks cGMP-dependent long-term depression at Schaffer collateral-CA1 hippocampal synapses
Copyright policy )Gαi2 inhibition of adenylate cyclase regulates presynaptic activity and unmasks cGMP-dependent long-term depression at Schaffer collateral-CA1 hippocampal synapses
Cyclic AMP signaling plays a central role in regulating activity at a number of synapses in the brain. We showed previously that pairing activation of receptors that inhibit adenylate cyclase (AC) and reduce the concentration of cyclic AMP, with elevation of the concentration of cyclic GMP is sufficient to elicit a presynaptically expressed form of LTD at Schaffer collateral-CA1 synapses in the hippocampus. To directly test the role of AC inhibition and G-protein signaling in LTD at these synapses, we utilized transgenic mice that express a mutant, constitutively active inhibitory G protein, Gαi2, in principal neurons of the forebrain. Transgene expression of Gαi2 markedly enhanced LTD and impaired late-phase LTP at Schaffer collateral synapses, with no associated differences in input/output relations, paired-pulse facilitation, or NMDA receptor-gated conductances. When paired with application of a type V phosphodiesterase inhibitor to elevate the concentration of intracellular cyclic GMP, constitutively active Gαi2 expression converted the transient depression normally caused by this treatment to an LTD that persisted after the drug was washed out. Moreover, this effect could be mimicked in control slices by pairing type V phosphodiesterase inhibitor application with application of a PKA inhibitor. Electrophysiological recordings of spontaneous excitatory postsynaptic currents and two-photon visualization of vesicular release using FM1-43 revealed that constitutively active Gαi2 tonically reduced basal release probability from the rapidly recycling vesicle pool of Schaffer collateral terminals. Our findings support the hypothesis that inhibitory G-protein signaling acts presynaptically to regulate release, and, when paired with elevations in the concentration of cyclic GMP, converts a transient cyclic GMP-induced depression into a long-lasting decrease in release.
- King’s University United States
- Howard Hughes Medical Institute United States
- University of Bath United Kingdom
- University of New Mexico United States
- New York Medical College United States
Depression, Phosphodiesterase Inhibitors, Long-Term Potentiation, Intracellular Signaling Peptides and Proteins, Drug Synergism, Mice, Transgenic, GTP-Binding Protein alpha Subunits, Gi-Go, Phosphodiesterase 5 Inhibitors, Receptors, Presynaptic, Hippocampus, Disease Models, Animal, Mice, GTP-Binding Protein Regulators, Adenylyl Cyclase Inhibitors, Synapses, Animals, Enzyme Inhibitors, Cyclic GMP
Depression, Phosphodiesterase Inhibitors, Long-Term Potentiation, Intracellular Signaling Peptides and Proteins, Drug Synergism, Mice, Transgenic, GTP-Binding Protein alpha Subunits, Gi-Go, Phosphodiesterase 5 Inhibitors, Receptors, Presynaptic, Hippocampus, Disease Models, Animal, Mice, GTP-Binding Protein Regulators, Adenylyl Cyclase Inhibitors, Synapses, Animals, Enzyme Inhibitors, Cyclic GMP
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).15 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!